Miriam Whitfield, Jasmine B Hollywood, Andrea Keister
{"title":"Nutritional Management of Hashimoto's Thyroiditis: A Case Report.","authors":"Miriam Whitfield, Jasmine B Hollywood, Andrea Keister","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Hashimoto's thyroiditis (HT) is prevalent in about 1 in 1000 people. A 39-year-old female diagnosed with HT was having unsuccessful symptom resolution with conventional thyroxine (T4) replacement therapy. In 60 days, there was a remarkable reduction of thyroid antibodies (Ab), improvement of thyroid hormones, and cardiometabolic biomarkers following a Paleolithic diet (PD).</p><p><strong>Case description: </strong>A patient unable to lose weight or alleviate gastrointestinal and neurological symptoms after maintaining clinical thyroid stimulating hormone (TSH) levels through conventional T4 medication therapy saw significant reductions in thyroglobulin (47.5%) and thyroid peroxidase (28.9%) Abs, and significant improvement in TSH (36.4%) total T4 (21.5%) and total T3 (33.3%) after 60-day treatment intervention with the PD. Improvements were also seen in HDL (31.6%), LDL (8.9%), total cholesterol (14.9%), and weight (11.5%). The client adhered to a weekly step process of avoidance of foods that have known hypersensitivities and consumed high-quality fats, fermented foods, filtered water, and green tea, and took a daily nutritional supplementation of vitamin D used in conjunction with a homemade turmeric spice blend. Upon final follow-up, the client had a remarkable reduction in symptoms.</p><p><strong>Conclusion: </strong>The Paleolithic diet may be used as a nutritional therapeutic protocol in those with HT with who have complications reducing weight and alleviating gastrointestinal and neurological symptoms no adverse events. Future research should be performed on larger, more diverse populations to develop population-based clinical practice guidelines. Specific areas of research, such as the long-term effects of the PD on HT, comparisons with conventional treatments, and exploring the mechanisms by which PD influences HT symptoms and markers will be beneficial to this research.</p>","PeriodicalId":34899,"journal":{"name":"Advances in Mind-Body Medicine","volume":"28 2","pages":"22-27"},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Mind-Body Medicine","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Hashimoto's thyroiditis (HT) is prevalent in about 1 in 1000 people. A 39-year-old female diagnosed with HT was having unsuccessful symptom resolution with conventional thyroxine (T4) replacement therapy. In 60 days, there was a remarkable reduction of thyroid antibodies (Ab), improvement of thyroid hormones, and cardiometabolic biomarkers following a Paleolithic diet (PD).
Case description: A patient unable to lose weight or alleviate gastrointestinal and neurological symptoms after maintaining clinical thyroid stimulating hormone (TSH) levels through conventional T4 medication therapy saw significant reductions in thyroglobulin (47.5%) and thyroid peroxidase (28.9%) Abs, and significant improvement in TSH (36.4%) total T4 (21.5%) and total T3 (33.3%) after 60-day treatment intervention with the PD. Improvements were also seen in HDL (31.6%), LDL (8.9%), total cholesterol (14.9%), and weight (11.5%). The client adhered to a weekly step process of avoidance of foods that have known hypersensitivities and consumed high-quality fats, fermented foods, filtered water, and green tea, and took a daily nutritional supplementation of vitamin D used in conjunction with a homemade turmeric spice blend. Upon final follow-up, the client had a remarkable reduction in symptoms.
Conclusion: The Paleolithic diet may be used as a nutritional therapeutic protocol in those with HT with who have complications reducing weight and alleviating gastrointestinal and neurological symptoms no adverse events. Future research should be performed on larger, more diverse populations to develop population-based clinical practice guidelines. Specific areas of research, such as the long-term effects of the PD on HT, comparisons with conventional treatments, and exploring the mechanisms by which PD influences HT symptoms and markers will be beneficial to this research.
简介桥本氏甲状腺炎(HT)的发病率约为千分之一。一名 39 岁的女性被确诊为桥本氏甲状腺炎,传统的甲状腺素(T4)替代疗法无法成功缓解症状。在采用旧石器时代饮食(PD)60天后,她的甲状腺抗体(Ab)明显降低,甲状腺激素和心脏代谢生物标志物也得到改善:一位患者在通过传统T4药物治疗维持临床促甲状腺激素(TSH)水平后,体重仍无法减轻,胃肠道和神经系统症状也无法缓解,但在采用旧石器时代饮食(PD)进行为期60天的治疗干预后,患者的甲状腺球蛋白(47.5%)和甲状腺过氧化物酶(28.9%)Ab显著降低,促甲状腺激素(36.4%)、总T4(21.5%)和总T3(33.3%)显著改善。高密度脂蛋白(31.6%)、低密度脂蛋白(8.9%)、总胆固醇(14.9%)和体重(11.5%)也有改善。客户坚持每周一次避免食用已知过敏的食物,并摄入优质脂肪、发酵食品、过滤水和绿茶,每天补充维生素 D 和自制姜黄混合香料。在最后的随访中,客户的症状明显减轻:旧石器时代饮食可作为一种营养治疗方案,用于有并发症的高血压患者,可减轻体重,缓解胃肠道和神经系统症状,且无不良反应。未来的研究应针对更大、更多样化的人群,以制定基于人群的临床实践指南。具体的研究领域,如营养不良对高血压的长期影响、与传统治疗方法的比较,以及探索营养不良影响高血压症状和指标的机制,都将有益于这项研究。